Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
68.72 USD | +1.04% | +1.00% | +19.01% |
05:25pm | Edwards Lifesciences Corporation: The story continues | |
Apr. 19 | Nephron Research Raises Boston Scientific's Price Target to $80 From $75 | MT |
Official Publications
Proxy Statments | CO | |
SEC Filing 10K | CO | |
Slide show results | CO | |
Annual results | CO | |
SEC Filing 4K | CO | |
SEC Filing 8K | CO | |
Slide show Q3 | CO | |
3rd quarter results | CO | |
SEC Filing 10Q-3 | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-2 | CO | |
1st-half-year results | CO | |
SEC Filing 8K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 4K | CO | |
SEC Filing 10Q-1 | CO | |
1st quarter results | CO | |
Proxy Statments | CO |
- Stock Market
- Equities
- BSX Stock
- News Boston Scientific Corporation
- Official Publications